Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stuschke

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
Der Urologe. Ausg. A|June 29, 2007
[Proapoptotic antibodies as new therapeutic agents for tumor treatment]M Schenck, C Börgermann, F vom Dorp, et al.
European Journal of Medical Research|September 3, 1999
Increased levels of vascular endothelial growth factor in bronchoalveolar lavage of patients with bronchial carcinoma effect of tumour activity and oxidative stress due to radio-chemotherapy?T Beinert, D Binder, C Oehm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trialM Guberina, W Eberhardt, M Stuschke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effectsM Stuschke, W Eberhardt, C Pöttgen, et al.
Frontiers of Radiation Therapy and Oncology|November 5, 1999
Commissioning of a micro-multileaf collimator for conformal stereotactic radiosurgery and radiotherapyR E Wurm, V P Cosgrove, L Schlenger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trialW Eberhardt, H Wilke, G Stamatis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 2, 2021
Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD-1 inhibitorsP Jansen, G C Lodde, A Wetter, et al.
British Journal of Cancer|December 10, 1999
Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trialW Eberhardt, G Stamatis, M Stuschke, et al.
Journal of Cancer Research and Clinical Oncology|September 2, 2008
Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin's lymphomaP Schütt, K Zimmermann, C Derks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trialM Stahl, H Wilke, U Fink, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Der Urologe. Ausg. A|June 29, 2007
[Proapoptotic antibodies as new therapeutic agents for tumor treatment]M Schenck, C Börgermann, F vom Dorp, et al.
European Journal of Medical Research|September 3, 1999
Increased levels of vascular endothelial growth factor in bronchoalveolar lavage of patients with bronchial carcinoma effect of tumour activity and oxidative stress due to radio-chemotherapy?T Beinert, D Binder, C Oehm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trialM Guberina, W Eberhardt, M Stuschke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effectsM Stuschke, W Eberhardt, C Pöttgen, et al.
Frontiers of Radiation Therapy and Oncology|November 5, 1999
Commissioning of a micro-multileaf collimator for conformal stereotactic radiosurgery and radiotherapyR E Wurm, V P Cosgrove, L Schlenger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trialW Eberhardt, H Wilke, G Stamatis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 2, 2021
Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD-1 inhibitorsP Jansen, G C Lodde, A Wetter, et al.
British Journal of Cancer|December 10, 1999
Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trialW Eberhardt, G Stamatis, M Stuschke, et al.
Journal of Cancer Research and Clinical Oncology|September 2, 2008
Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin's lymphomaP Schütt, K Zimmermann, C Derks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trialM Stahl, H Wilke, U Fink, et al.
Pageof 14